Mutual Of America Capital Management LLC Amgen Inc Transaction History

Mutual Of America Capital Management LLC

  • $9.32 Billion
  • Q3 2024

A detailed history of Mutual Of America Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 66,316 shares of AMGN stock, worth $18.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
66,316
Previous 68,273 2.87%
Holding current value
$18.8 Million
Previous $21.3 Million 0.17%
% of portfolio
0.23%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$309.38 - $337.38 $605,456 - $660,252
-1,957 Reduced 2.87%
66,316 $21.4 Million
Q2 2024

Aug 09, 2024
SELL
$262.75 - $319.31 $596,968 - $725,472
-2,272 Reduced 3.22%
68,273 $21.3 Million
Q1 2024

May 02, 2024
SELL
$268.87 - $324.56 $265,374 - $320,340
-987 Reduced 1.38%
70,545 $20.1 Million
Q4 2023

Jan 26, 2024
SELL
$255.7 - $288.46 $827,956 - $934,033
-3,238 Reduced 4.33%
71,532 $20.6 Million
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $439,049 - $545,091
-2,008 Reduced 2.62%
74,770 $20.1 Million
Q2 2023

Aug 11, 2023
BUY
$214.27 - $253.37 $95,135 - $112,496
444 Added 0.58%
76,778 $17 Million
Q1 2023

May 04, 2023
BUY
$225.79 - $275.2 $41,545 - $50,636
184 Added 0.24%
76,334 $18.5 Million
Q4 2022

Feb 10, 2023
BUY
$229.03 - $291.01 $493,788 - $627,417
2,156 Added 2.91%
76,150 $20 Million
Q3 2022

Nov 08, 2022
BUY
$224.46 - $253.15 $265,087 - $298,970
1,181 Added 1.62%
73,994 $16.7 Million
Q2 2022

Aug 10, 2022
SELL
$230.71 - $256.74 $528,556 - $588,191
-2,291 Reduced 3.05%
72,813 $17.7 Million
Q1 2022

May 02, 2022
BUY
$219.27 - $242.57 $171,907 - $190,174
784 Added 1.05%
75,104 $18.2 Million
Q4 2021

Feb 03, 2022
SELL
$198.88 - $227.6 $28,042 - $32,091
-141 Reduced 0.19%
74,320 $16.7 Million
Q3 2021

Nov 10, 2021
SELL
$212.27 - $248.7 $952,243 - $1.12 Million
-4,486 Reduced 5.68%
74,461 $15.8 Million
Q2 2021

Aug 06, 2021
BUY
$233.58 - $259.14 $89,694 - $99,509
384 Added 0.49%
78,947 $19.2 Million
Q1 2021

May 13, 2021
BUY
$221.91 - $258.6 $96,087 - $111,973
433 Added 0.55%
78,563 $19.5 Million
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $297,955 - $354,811
-1,377 Reduced 1.73%
78,130 $18 Million
Q3 2020

Nov 13, 2020
SELL
$234.65 - $260.95 $134,454 - $149,524
-573 Reduced 0.72%
79,507 $20.2 Million
Q2 2020

Aug 06, 2020
SELL
$197.81 - $242.74 $181,193 - $222,349
-916 Reduced 1.13%
80,080 $18.9 Million
Q1 2020

May 11, 2020
BUY
$182.24 - $241.7 $189,529 - $251,368
1,040 Added 1.3%
80,996 $16.4 Million
Q4 2019

Feb 11, 2020
SELL
$189.21 - $243.2 $51,086 - $65,664
-270 Reduced 0.34%
79,956 $19.3 Million
Q3 2019

Nov 14, 2019
SELL
$174.11 - $208.62 $2.89 Million - $3.46 Million
-16,583 Reduced 17.13%
80,226 $15.5 Million
Q2 2019

Aug 12, 2019
SELL
$166.7 - $195.41 $50,176 - $58,818
-301 Reduced 0.31%
96,809 $17.8 Million
Q1 2019

May 13, 2019
SELL
$180.87 - $203.88 $2 Million - $2.25 Million
-11,044 Reduced 10.21%
97,110 $18.4 Million
Q4 2018

Feb 12, 2019
BUY
$178.4 - $208.25 $708,426 - $826,960
3,971 Added 3.81%
108,154 $21.1 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $485,459 - $547,291
-2,620 Reduced 2.45%
104,183 $21.6 Million
Q2 2018

Aug 09, 2018
BUY
$166.05 - $186.51 $23,579 - $26,484
142 Added 0.13%
106,803 $19.7 Million
Q1 2018

May 11, 2018
SELL
$169.43 - $198.0 $1.03 Million - $1.2 Million
-6,050 Reduced 5.37%
106,661 $18.2 Million
Q4 2017

Jan 31, 2018
BUY
$168.79 - $188.59 $4.14 Million - $4.63 Million
24,525 Added 27.81%
112,711 $19.6 Million
Q3 2017

Oct 18, 2017
BUY
$167.29 - $191.0 $14.8 Million - $16.8 Million
88,186
88,186 $16.4 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email